In this eye-opening episode, we sit down with Heather, a seasoned business development expert at Chrysalis Bio, who reveals the hidden communication breakdowns that derail tech transfers long before any scientific issues arise.

What You'll Learn:

• Why most companies approach tech transfer reactively instead of proactively—and how this costs millions
• The shocking disconnect between business development and operations that leads to "wrong client" scenarios
• How 30% attrition in analytical teams still doesn't solve communication problems
• The three ways CDMOs grow in the market (and why two approaches are fundamentally flawed)
• Why proximity matters less than you think, but supply chain management could be your biggest differentiator
• The untapped opportunity in case management that most CDMOs are missing

Key Insight: "You don't have those systems in place, so you're forcing a process to happen based on need versus based on understanding. Information can get lost. Disconnects can happen, wrong information gets transferred, timelines then get pushed out."

Heather shares real-world examples from her experience in cell and gene therapy CDMOs, revealing how the industry's rapid growth has created expertise gaps and why building proactive communication systems is critical for success.

Whether you're a startup planning your first tech transfer or a CDMO looking to differentiate your services, this episode provides actionable insights for preventing the costly miscommunications that plague the industry.

Perfect for: Biotech executives, CDMO professionals, process development teams, and anyone involved in technology transfer in life sciences.